Evaluation the effect of nanoniosomal cisplatin on brain cancer cell line C6
Author(s):
Abstract:
Aim and
Material and
Background
Nowadays, applying nanocarriers has increased dramatically in drug delivery systems. Niosome is one of the nanocarriers with non-ionic surfactant which increases the stability of drug in the body. Since using cisplatin in treatment of cancer has some side effects, cisplatin was nanoniosomed.Material and
Methods
To prepare niosome, span 60 and cholesterol were used. Mean diameter of particles was determined by Zeta sizer. Encapsulation efficiency and drug release were measured by spectrophotometry method. Cytotoxicity effect of the formulation on C6 cell line was studied by MTT assay.Results
Mean diameter of particles was verified in scale of nano. Encapsulation efficiency and released in 48 hours were be 43.6% and 97%, respectively. The cytotoxicity effect of nanoniosomal cisplatin was 38.6 µg/ml.Conclusion
The present study showed that to reduce side effects of cisplatin and increase its toxicity, nanoniosomal formulation can be used.Keywords:
Drug delivery , Cisplatin , Niosome , MTT , C6
Language:
Persian
Published:
New Cellular & Molecular Biotechnology Journal, Volume:6 Issue: 23, 2016
Pages:
61 to 64
magiran.com/p1589878
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یکساله به مبلغ 1,390,000ريال میتوانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.
In order to view content subscription is required
Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!